Why Mikhail Blagosklonny Continues To Strive In the Field Of Cancer Treatment and Therapy Administration

Home / Why Mikhail Blagosklonny Continues To Strive In the Field Of Cancer Treatment and Therapy Administration

Professionalism in the healthcare sectors has been termed as the only sure way of getting qualified medical practitioners and doctors. This will ensure good service delivery with many people accessing affordable healthcare across the world. This has also facilitated the emergence of many doctors across the world who have contributed towards advancement of affordable and better healthcare treatment. As such, cancer is one of the chronic diseases that has been affecting many people across the world. People have been dying due to cancer related complication and some have not been able to access treatment due to the expensive nature of the treatment. This has necessitated the emergence of many professional doctors that have undertaken the study of cancer and have developed ways of reducing it fatal nature. Mikhail Blagosklonny is a leading doctor of cancer and has been developing rugs and therapies that are affordable to the general public. He is a professor of oncology from the Roswell Park Cancer Institute situated in New York City in United States of America. This has been his expertise in the cancer and aging field and he has continued to impact on the lives of people by always improving on the available drugs. He received his master’s degree subsequently his Ph.D. degree from the First Pavlov State medical University in St. Petersburg. This was his breakthrough into the world of cancer treatment as he had already gotten the necessary skills and knowledge to find and improve on the cancer drugs and therapy administration.

Mikhail Blagosklonny has been contributing more in educating the general public on how to handle cancer patients. As such, he has been studying on how to mitigate cancer while targeting only cancer cells without damaging the other normal body cells. He is the editor-in-chief of the Oncotarget. This is a weekly journal review that has been providing members of the public insight about the development and result achieved in the oncology field. The publication has received many reviews making it one of the most important journal that has attracted many people across the world. He has also participated in the publication of over 300 journals. Follow his LinkedIn profile to know more.